Trials / Sponsors / Suzhou Immunofoco Biotechnology Co., Ltd
Suzhou Immunofoco Biotechnology Co., Ltd
Industry · 5 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study of IMV102 in Patients With Relapsed/Refractory Multiple Myeloma Relapsed/Refractory Multiple Myeloma | EARLY_Phase 1 | 2026-03-31 |
| Recruiting | A Phase I/IIa, Open-label, Single-center, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Tol Relapsed/Refractory B-cell Non-Hodgkin Lymphoma | EARLY_Phase 1 | 2025-12-29 |
| Recruiting | A Phase III Randomized Study in CLDN18.2-positive Unresectable Locally Advanced Gastric Cancer Patients Gastric Adenocarcinoma | Phase 3 | 2025-08-06 |
| Unknown | A Phase I Trial to Evaluate the Safety of IMC002 in Advanced Digestive System Tumors Advanced Digestive System Tumor | Phase 1 | 2023-09-07 |
| Unknown | Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 Expression Gastric Cancer, Pancreatic Cancer, Advanced Ovarian Carcinoma | Phase 1 | 2022-08-08 |